OptMed, Inc. (OMED)
OptMed was planning to go public, but the IPO was withdrawn on Jun 12, 2023.
Stock Price: Pending
IPO price not available yet

OptMed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
1.811.62
Research & Development
1.030.9
Operating Expenses
2.842.52
Operating Income
-2.84-2.52
Interest Expense / Income
4.333.52
Other Expense / Income
-2.78-2.65
Pretax Income
-4.33-3.36
Net Income
-4.38-3.38
Net Income Common
-4.33-3.36
Free Cash Flow
-1.99-2.27
EBITDA
0.870.77
Depreciation & Amortization
0.920.64
EBIT
-0.050.13
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).